These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2104084)

  • 1. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome.
    O'Donnell LJ; Watson AJ; Cameron D; Farthing MJ
    Aliment Pharmacol Ther; 1990 Apr; 4(2):177-81. PubMed ID: 2104084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single doses of ritodrine delay orocaecal transit in patients with irritable bowel syndrome.
    Basilisco G; Camboni MG; Bozzani A; Molgora M; Bianchi PA
    Br J Clin Pharmacol; 1990 Mar; 29(3):355-8. PubMed ID: 2310659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.
    Houghton LA; Foster JM; Whorwell PJ
    Aliment Pharmacol Ther; 2000 Jun; 14(6):775-82. PubMed ID: 10848662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed mouth-caecum transit of a lactulose labelled liquid test meal in patients with steatorrhoea caused by partially treated coeliac disease.
    Spiller RC; Lee YC; Edge C; Ralphs DN; Stewart JS; Bloom SR; Silk DB
    Gut; 1987 Oct; 28(10):1275-82. PubMed ID: 3678957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.
    Veysey MJ; Thomas LA; Mallet AI; Jenkins PJ; Besser GM; Wass JA; Murphy GM; Dowling RH
    Gut; 1999 May; 44(5):675-81. PubMed ID: 10205204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.
    Veysey MJ; Malcolm P; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
    Gut; 2001 Dec; 49(6):828-34. PubMed ID: 11709518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.
    Hebden JM; Blackshaw E; D'Amato M; Perkins AC; Spiller RC
    Am J Gastroenterol; 2002 Sep; 97(9):2315-20. PubMed ID: 12358250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of clonidine on oro-cecal transit time in normal man].
    Baumer P; Danays T; Lion L; Cosnes J; Gendre JP; Le Quintrec Y
    Ann Gastroenterol Hepatol (Paris); 1989; 25(1):5-9. PubMed ID: 2653174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome.
    Corbett CL; Thomas S; Read NW; Hobson N; Bergman I; Holdsworth CD
    Gut; 1981 Oct; 22(10):836-40. PubMed ID: 7297914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time.
    Ladas SD; Latoufis C; Giannopoulou H; Hatziioannou J; Raptis SA
    Dig Dis Sci; 1989 Jun; 34(6):919-24. PubMed ID: 2656138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome.
    Gorard DA; Libby GW; Farthing MJ
    Aliment Pharmacol Ther; 1994 Apr; 8(2):159-66. PubMed ID: 8038347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome.
    Passaretti S; Guslandi M; Imbimbo BP; Daniotti S; Tittobello A
    Aliment Pharmacol Ther; 1989 Jun; 3(3):267-76. PubMed ID: 2520622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man.
    Møller N; Petrany G; Cassidy D; Sheldon WL; Johnston DG; Laker MF
    Clin Sci (Lond); 1988 Oct; 75(4):345-50. PubMed ID: 3058374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study.
    Lu CL; Chen CY; Chang FY; Lee SD
    Clin Sci (Lond); 1998 Aug; 95(2):165-9. PubMed ID: 9680498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans.
    Ladas SD; Frydas A; Papadopoulos A; Raptis SA
    Gut; 1992 Sep; 33(9):1246-8. PubMed ID: 1427379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating.
    Di Stefano M; Miceli E; Missanelli A; Mazzocchi S; Tana P; Corazza GR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1242-7. PubMed ID: 16979386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.
    Yu D; Cheeseman F; Vanner S
    Gut; 2011 Mar; 60(3):334-40. PubMed ID: 21112950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit.
    Houghton LA; Jackson NA; Whorwell PJ; Cooper SM
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1437-44. PubMed ID: 10571599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance].
    Błońska A; Konrad P; Chojnacki J; Chojnacki C
    Pol Merkur Lekarski; 2017 Mar; 42(249):116-120. PubMed ID: 28333903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.
    Prather CM; Camilleri M; Zinsmeister AR; McKinzie S; Thomforde G
    Gastroenterology; 2000 Mar; 118(3):463-8. PubMed ID: 10702196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.